期刊文献+

抗糖尿病新药(D-Ser2)Oxm拮抗淀粉样β蛋白细胞毒性的神经保护效应观察 被引量:3

Neuroprotective effects of a novel antidiabetic drug (D-Ser2)Oxm on amyloid β protein-induced cytotoxicity
原文传递
导出
摘要 淀粉样β蛋白(amyloidβ-protein,Aβ)在脑内的沉积及其神经毒性是阿尔茨海默病(Alzheimer’s disease,AD)的主要原因之一,目前仍缺乏拮抗Aβ的有效药物。最新报道表明,一种新的抗糖尿病药物(D-Ser2)Oxm不仅可以改善2型糖尿病(T2DM)大鼠的血糖和胰岛素水平,也具有促进皮层和海马神经元及其突触发生的效应。然而,(D-Ser2)Oxm是否能拮抗AD时Aβ所致的细胞损伤仍缺乏实验依据。本研究在培养原代大鼠海马神经细胞基础上,通过细胞活性和早期凋亡测定、细胞内钙成像以及线粒体膜电位检测,研究了(D-Ser2)Oxm对Aβ1-42所致细胞毒性的拮抗效应。结果显示,与单独给予Aβ1-42处理的细胞相比,(D-Ser2)Oxm+Aβ1-42处理组的细胞活力明显提高,而加入GLP-1受体抑制剂exendin(9-39)后,细胞活力则显著下降;(D-Ser2)Oxm可有效拮抗Aβ1-42导致的细胞凋亡,并使凋亡相关蛋白caspase3含量显著降低;(D-Ser2)Oxm处理还有效阻止了Aβ1-42引起的海马细胞内钙水平升高、线粒体膜电位去极化以及糖原合成酶激酶-3β(glycogen synthase kinase-3β,GSK-3β)(Y216)的活化。以上结果表明,(D-Ser2)Oxm可能是通过激动GLP-1受体对抗Aβ1-42的神经毒性,并且这种保护效应可能与细胞内钙稳态调节和线粒体膜电位稳定有关。 The accumulation and neurotoxicity of amyloid β protein(Aβ) in the brain is one of major pathological hallmarks of Alzheimer's disease(AD). The effective drugs against Aβ have been still deficient up to now. According to a most recent study,(D-Ser2)Oxm, a new antidiabetic drug, not only improves the disorders in plasma glucose and insulin in type 2 diabetes mellitus(T2DM) rats, but also exerts positive effects on hippocampal neurogenesis and synaptogenesis. However, it is still unclear whether(D-Ser2)Oxm can directly protect cultured neurons against Aβ1-42-induced cytotoxicity. In the present study, we investigated the neuroprotective effects of(D-Ser2)Oxm on the cultured primary hippocampal neurons by testing the cell viability, neuronal apoptosis, mitochondrial membrane potential and intracellular calcium concentration. The results showed that treatment with(D-Ser2)Oxm effectively reversed Aβ1-42-induced decline in cell viability(P 0.001), and this protective effect could be inhibited by the pretreatment with exendin(9-39), a GLP-1 receptor blocker.(D-Ser2)Oxm treatment also decreased Aβ1-42-induced neuronal early apoptosis and down-regulated apoptotic protein caspase3. Meantime,(D-Ser2)Oxm treatment inhibited Aβ1-42-induced [Ca2+]i elevation, mitochondrial membrane potential depolarization, and glycogen synthase kinase-3β(GSK3β) activation. These results suggest that(D-Ser2)Oxm can protect hippocampal neurons against Aβ1-42-induced cytotoxicity and this effect may be related to activation of GLP-1 receptors, regulation of intracellular calcium homeostasis and stabilization of mitochondrial membrane potential.
出处 《生理学报》 CAS CSCD 北大核心 2016年第3期265-275,共11页 Acta Physiologica Sinica
基金 supported by the National Natural Science Foundation of China(No.31471080,31271201) the College Science and Technology Innovation Foundation of Shanxi Province,China(No.2015153)
关键词 (D-Ser2)Oxm 淀粉样Β蛋白 细胞凋亡 CASPASE3 细胞内钙成像 线粒体膜电位 GSK3Β 海马神经元 (D-Ser2)Oxm amyloid β protein cellular apoptosis caspase3 intracellular calcium imaging mitochondrial membrane potential glycogen synthase kinase-3β hippocampal neuron
  • 相关文献

参考文献1

二级参考文献31

  • 1Guglielmotto M, Aragno M, Tamagno E, Vercellinatto I, Visentin S, Medana C, et alo AGEs/RAGE complex upregulates BACE1 via NF- kappaB pathway activation. Neurobiol Aging 2010. doi: 10.1016/ j.neurobiolaging.2010.05.026.
  • 2McCall AL. The impact of diabetes on the CNS. Diabetes 1992; 41: 557-70.
  • 3Wang SH, Sun ZL, Guo Y J, Yuan Y, Li L. PPARy-mediated advanced glycation end products regulation of neural stem cells. Mol Cell Endocrinol 2009; 307: 176-84.
  • 4Munch G, Schinzel R, Loske C, Wong A, Durany N, Li J J, et al. Alzheimer's disease -- synergistic effects of glucose deficit, oxidative stress and advanced glycation endproducts. J Neural Transm 1998; 105: 439-61.
  • 5Mruthinti S, Sood A, Humphrey CL, Swamy-Mruthinti S, Buccafusco JJ. The induction of surface beta-amyloid binding proteins and enhanced cytotoxicity in cultured PC-12 and IMR-32 cells by advanced glycation end products. Neuroscience 2006; 142: 463-73.
  • 6Woltjer RL, Maezawa I, Ou J J, Montine KS, Montine TJ. Advanced glycation endproduct precursor alters intracellular amyloid-beta/ A beta PP carboxy-terminal fragment aggregation and cytotoxicity. J Alzheimers Dis 2003; 5: 467-76.
  • 7Loske C, Neumann A, Cunningham AM, Nichol K, Schinzel R, Riederer P, et al. Cytotoxicity of advanced glycation endproducts is mediated by oxidative stress. J Neural Transm 1998; 105: 1005-15.
  • 8Gasic-Milenkovic J, Loske C, Deuther-Conrad W, Munch G. Protein "AGEing" - cytotoxicity of a glycated protein increases with its degree of AGE-modification. Z Gerontol Geriatr 2001; 34: 457-60.
  • 9Deuther-Conrad W, Loske C, Schinzel R, Dringen R, Riederer P, Munch G. Advanced glycation endproducts change glutathione redox status in SH-SY5Y human neuroblastoma cells by a hydrogen peroxide dependent mechanism. Neurosci Lett 2001; 312: 29-32.
  • 10Wei Y, Chen L, Chen J, Ge L, He RQ. Rapid glycation with D-ribose induces globular amyloid-like aggregations of BSA with high cytotoxi- city to SH-SY5Y cells. BMC Cell Biol 2009; 10: 10.

共引文献4

同被引文献9

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部